Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	axonogenesis	MAG PLXNA3 EPHA6 ANK3 MAP1B USP9X ATP8A2 POU4F3 LHX9 PLEKHG4B LRP4 AGRN EPHA5	2.47e-06	566	97	13	GO:0007409
GeneOntologyBiologicalProcess	axon development	MAG PLXNA3 EPHA6 ANK3 MAP1B USP9X ATP8A2 POU4F3 LHX9 PLEKHG4B LRP4 AGRN EPHA5	9.64e-06	642	97	13	GO:0061564
GeneOntologyBiologicalProcess	neuromuscular junction development	ANK3 FZD9 P2RX2 LRP4 AGRN	1.71e-05	68	97	5	GO:0007528
GeneOntologyBiologicalProcess	regulation of skeletal muscle acetylcholine-gated channel clustering	FZD9 LRP4 AGRN	4.40e-05	15	97	3	GO:1904393
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	MAG PLXNA3 EPHA6 ANK3 MAP1B USP9X ATP8A2 POU4F3 LHX9 PLEKHG4B LRP4 AGRN EPHA5	4.76e-05	748	97	13	GO:0048667
GeneOntologyBiologicalProcess	axon guidance	PLXNA3 EPHA6 ANK3 POU4F3 LHX9 PLEKHG4B AGRN EPHA5	6.01e-05	285	97	8	GO:0007411
GeneOntologyBiologicalProcess	neuron projection guidance	PLXNA3 EPHA6 ANK3 POU4F3 LHX9 PLEKHG4B AGRN EPHA5	6.16e-05	286	97	8	GO:0097485
GeneOntologyBiologicalProcess	cerebellar cortex structural organization	USP9X DLL1	6.55e-05	3	97	2	GO:0021698
GeneOntologyBiologicalProcess	neuron projection morphogenesis	MAG PLXNA3 EPHA6 ANK3 MAP1B USP9X ATP8A2 POU4F3 LHX9 PLEKHG4B LRP4 AGRN EPHA5	9.63e-05	802	97	13	GO:0048812
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	MAG PLXNA3 EPHA6 ANK3 MAP1B USP9X ATP8A2 POU4F3 LHX9 PLEKHG4B LRP4 AGRN EPHA5	1.19e-04	819	97	13	GO:0120039
GeneOntologyBiologicalProcess	skeletal muscle acetylcholine-gated channel clustering	FZD9 LRP4 AGRN	1.26e-04	21	97	3	GO:0071340
GeneOntologyBiologicalProcess	anatomical structure arrangement	PLXNA3 USP9X DLL1	1.26e-04	21	97	3	GO:0048532
GeneOntologyBiologicalProcess	cell projection morphogenesis	MAG PLXNA3 EPHA6 ANK3 MAP1B USP9X ATP8A2 POU4F3 LHX9 PLEKHG4B LRP4 AGRN EPHA5	1.29e-04	826	97	13	GO:0048858
GeneOntologyBiologicalProcess	negative regulation of cellular component organization	MAG PLXNA3 RAP1GAP ANK3 MAP1B KANK2 FZD9 PER2 CSPG4 BUB1B RHPN2P1 LRP4 FER1L5	2.01e-04	864	97	13	GO:0051129
GeneOntologyBiologicalProcess	negative regulation of cell differentiation	MAG PLXNA3 ASXL1 RAP1GAP CDK12 PRAMEF2 DLL1 FGF23 IGFBP5 LRP4 KDM4A NBR1 PRDM6	2.27e-04	875	97	13	GO:0045596
GeneOntologyBiologicalProcess	regulation of receptor clustering	FZD9 LRP4 AGRN	3.37e-04	29	97	3	GO:1903909
MousePheno	premature death	ASXL1 WWOX ANK3 MAP1B ATP8A2 TCIRG1 POU4F3 DLL1 MCOLN1 FZD9 FGF23 PER2 CD22 BUB1B KCNMA1 SERPINC1 AGRN SON	1.18e-05	1051	77	18	MP:0002083
Domain	PAS	PDE8A PER3 PER2 PDE8B	2.03e-05	32	95	4	SM00091
Domain	PDEase_PDE8	PDE8A PDE8B	2.56e-05	2	95	2	IPR013938
Domain	PAS	PDE8A PER3 PER2 PDE8B	2.59e-05	34	95	4	PS50112
Domain	PAS	PDE8A PER3 PER2 PDE8B	2.59e-05	34	95	4	IPR000014
Domain	Period_circadian-like_C	PER3 PER2	7.65e-05	3	95	2	IPR022728
Domain	Period_C	PER3 PER2	7.65e-05	3	95	2	PF12114
Domain	PAS-assoc_C	PDE8A PER3 PER2	2.39e-04	24	95	3	IPR000700
Domain	PAC	PDE8A PER3 PER2	3.04e-04	26	95	3	PS50113
Domain	SET	ASH1L PRDM11 PRDM6	1.18e-03	41	95	3	PF00856
Domain	Growth_fac_rcpt_	EPHA6 DLL1 IGFBP5 LRP4 EPHA5	1.21e-03	156	95	5	IPR009030
Domain	PKD_channel	PKDREJ MCOLN1	1.37e-03	11	95	2	PF08016
Domain	Laminin_G_1	CSPG4 AGRN	1.37e-03	11	95	2	PF00054
Domain	PKD1_2_channel	PKDREJ MCOLN1	1.37e-03	11	95	2	IPR013122
Domain	SET	ASH1L PRDM11 PRDM6	1.65e-03	46	95	3	SM00317
Domain	SET_dom	ASH1L PRDM11 PRDM6	2.10e-03	50	95	3	IPR001214
Domain	SET	ASH1L PRDM11 PRDM6	2.10e-03	50	95	3	PS50280
Domain	RECEPTOR_TYR_KIN_V_2	EPHA6 EPHA5	2.24e-03	14	95	2	PS00791
Domain	RECEPTOR_TYR_KIN_V_1	EPHA6 EPHA5	2.24e-03	14	95	2	PS00790
Domain	Tyr_kinase_rcpt_V_CS	EPHA6 EPHA5	2.24e-03	14	95	2	IPR001426
Domain	EphA2_TM	EPHA6 EPHA5	2.24e-03	14	95	2	PF14575
Domain	Ephrin_rcpt_lig-bd_dom	EPHA6 EPHA5	2.24e-03	14	95	2	IPR001090
Domain	Eph_TM	EPHA6 EPHA5	2.24e-03	14	95	2	IPR027936
Domain	EPH_lbd	EPHA6 EPHA5	2.24e-03	14	95	2	SM00615
Domain	Ephrin_lbd	EPHA6 EPHA5	2.24e-03	14	95	2	PF01404
Domain	Tyr_kinase_ephrin_rcpt	EPHA6 EPHA5	2.24e-03	14	95	2	IPR016257
Domain	EPH_LBD	EPHA6 EPHA5	2.24e-03	14	95	2	PS51550
Domain	ZF_MATRIN	ZNF318 ZMAT3	3.71e-03	18	95	2	PS50171
Domain	PDEase	PDE8A PDE8B	4.14e-03	19	95	2	IPR023088
Domain	PDEase_I	PDE8A PDE8B	5.05e-03	21	95	2	PF00233
Domain	PDEASE_I	PDE8A PDE8B	5.05e-03	21	95	2	PS00126
Domain	PDEase_CS	PDE8A PDE8B	5.05e-03	21	95	2	IPR023174
Pathway	WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS	RAP1GAP ANK3 KCNMA1 AGRN EPB41L1	3.30e-06	42	78	5	M39703
Pathway	WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS	RAP1GAP ANK3 KCNMA1 AGRN EPB41L1	3.30e-06	42	78	5	MM15822
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PLXNA3 CRYBG2 CDK12 REV3L DLL1 AATK IGF2R PER2 SLC16A5 CSPG4 ZNF500 HELZ2 NPRL3 LRP4 WDFY3 AGRN	1.23e-07	1105	101	16	35748872
Pubmed	PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord.	MAG PLXNA3 EPHA6 FZD9 LRIT1 EPHA5	1.24e-06	117	101	6	17145500
Pubmed	Dopamine adjusts the circadian gene expression of Per2 and Per3 in human dermal fibroblasts from ADHD patients.	PER3 PER2	8.35e-06	2	101	2	34275001
Pubmed	cAMP-specific phosphodiesterases 8A and 8B, essential regulators of Leydig cell steroidogenesis.	PDE8A PDE8B	8.35e-06	2	101	2	22232524
Pubmed	TGF-β-Induced Phosphorylation of Usp9X Stabilizes Ankyrin-G and Regulates Dendritic Spine Development and Maintenance.	ANK3 USP9X	8.35e-06	2	101	2	32460012
Pubmed	The high-affinity cAMP-specific phosphodiesterase 8B controls steroidogenesis in the mouse adrenal gland.	PDE8A PDE8B	8.35e-06	2	101	2	21187369
Pubmed	Possible Association of PER2/PER3 Variable Number Tandem Repeat Polymorphism Variants with Susceptibility and Clinical Characteristics in Pancreatic Cancer.	PER3 PER2	8.35e-06	2	101	2	33393850
Pubmed	BK calcium-activated potassium channels regulate circadian behavioral rhythms and pacemaker output.	PER2 KCNMA1	8.35e-06	2	101	2	16845385
Pubmed	Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses.	LRP4 AGRN	8.35e-06	2	101	2	22854782
Pubmed	A lysosomal K+ channel regulates large particle phagocytosis by facilitating lysosome Ca2+ release.	MCOLN1 KCNMA1	8.35e-06	2	101	2	31974459
Pubmed	A novel association of two non-synonymous polymorphisms in PER2 and PER3 genes with specific diurnal preference subscales.	PER3 PER2	8.35e-06	2	101	2	23969301
Pubmed	Microtubule-associated protein 1B: a neuronal binding partner for myelin-associated glycoprotein.	MAG MAP1B	8.35e-06	2	101	2	11733546
Pubmed	Variants in the circadian clock genes PER2 and PER3 associate with familial sleep phase disorders.	PER3 PER2	8.35e-06	2	101	2	38695651
Pubmed	MAP1B Interaction with the FW Domain of the Autophagic Receptor Nbr1 Facilitates Its Association to the Microtubule Network.	MAP1B NBR1	8.35e-06	2	101	2	22654911
Pubmed	Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans.	PDE8A PDE8B	8.35e-06	2	101	2	12681444
Pubmed	cAMP-specific phosphodiesterase 8A and 8B isoforms are differentially expressed in human testis and Leydig cell tumor.	PDE8A PDE8B	8.35e-06	2	101	2	36277728
Pubmed	Distinct functions of Period2 and Period3 in the mouse circadian system revealed by in vitro analysis.	PER3 PER2	8.35e-06	2	101	2	20072700
Pubmed	Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice.	EPHA6 DLL1 EPHA5	1.57e-05	17	101	3	12217323
Pubmed	Genetic variants associated with serum thyroid stimulating hormone (TSH) levels in European Americans and African Americans from the eMERGE Network.	WWOX IGFBP5 PDE8B	1.57e-05	17	101	3	25436638
Pubmed	Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.	AOC1 CDK12 IGF2R SLC16A5 CD22 NPRL3 VPS51	1.67e-05	276	101	7	28319085
Pubmed	Expression profiles of PERIOD1, 2, and 3 in peripheral blood mononuclear cells from older subjects.	PER3 PER2	2.50e-05	3	101	2	19013183
Pubmed	A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light.	PER3 PER2	2.50e-05	3	101	2	9428527
Pubmed	Low-Salt Diet and Circadian Dysfunction Synergize to Induce Angiotensin II-Dependent Hypertension in Mice.	PER3 PER2	2.50e-05	3	101	2	26781276
Pubmed	Two period homologs: circadian expression and photic regulation in the suprachiasmatic nuclei.	PER3 PER2	2.50e-05	3	101	2	9427249
Pubmed	Association between polymorphisms in period genes and bone density in postmenopausal Korean women.	PER3 PER2	2.50e-05	3	101	2	24678593
Pubmed	For whom the circadian clock ticks? Investigation of PERIOD and CLOCK gene variants in bipolar disorder.	PER3 PER2	2.50e-05	3	101	2	34112033
Pubmed	Photic entrainment of period mutant mice is predicted from their phase response curves.	PER3 PER2	2.50e-05	3	101	2	20826680
Pubmed	Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock.	PER3 PER2	2.50e-05	3	101	2	11395012
Pubmed	mPeriod2 Brdm1 and other single Period mutant mice have normal food anticipatory activity.	PER3 PER2	2.50e-05	3	101	2	29138421
Pubmed	A time memory engram embedded in a light-entrainable circadian clock.	PER3 PER2	2.50e-05	3	101	2	37951213
Pubmed	Bimodal regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity.	PER3 PER2	2.50e-05	3	101	2	12032351
Pubmed	Sex difference in daily rhythms of clock gene expression in the aged human cerebral cortex.	PER3 PER2	2.50e-05	3	101	2	23606611
Pubmed	MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.	LRP4 AGRN	2.50e-05	3	101	2	24244707
Pubmed	Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers.	PER3 PER2	2.50e-05	3	101	2	15790588
Pubmed	Unwinding the differences of the mammalian PERIOD clock proteins from crystal structure to cellular function.	PER3 PER2	2.50e-05	3	101	2	22331899
Pubmed	Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK).	LRP4 AGRN	2.50e-05	3	101	2	21969364
Pubmed	Aberrant expression of Per1, Per2 and Per3 and their prognostic relevance in non-small cell lung cancer.	PER3 PER2	2.50e-05	3	101	2	25550826
Pubmed	Inter-individual differences in habitual sleep timing and entrained phase of endogenous circadian rhythms of BMAL1, PER2 and PER3 mRNA in human leukocytes.	PER3 PER2	2.50e-05	3	101	2	18517031
Pubmed	A light-independent oscillatory gene mPer3 in mouse SCN and OVLT.	PER3 PER2	2.50e-05	3	101	2	9707434
Pubmed	Cell-surface glycoprotein of oligodendrocyte progenitors involved in migration.	MAG CSPG4	2.50e-05	3	101	2	10366628
Pubmed	Intracellular calcium mobilization induces period genes via MAP kinase pathways in NIH3T3 cells.	PER3 PER2	2.50e-05	3	101	2	11959112
Pubmed	Comparing expression levels of PERIOD genes PER1, PER2 and PER3 in chronic insomnia patients and medical staff working in the night shift.	PER3 PER2	2.50e-05	3	101	2	32805476
Pubmed	Sleep rhythmicity and homeostasis in mice with targeted disruption of mPeriod genes.	PER3 PER2	2.50e-05	3	101	2	15031135
Pubmed	Targeted Sequencing Reveals Low-Frequency Variants in EPHA Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy.	EPHA6 EPHA5	2.50e-05	3	101	2	27582484
Pubmed	The Circadian Clock Regulates Adipogenesis by a Per3 Crosstalk Pathway to Klf15.	PER3 PER2	2.50e-05	3	101	2	29186676
Pubmed	Nuclear export of mammalian PERIOD proteins.	PER3 PER2	2.50e-05	3	101	2	11591712
Pubmed	Period determination in the food-entrainable and methamphetamine-sensitive circadian oscillator(s).	PER3 PER2	2.50e-05	3	101	2	22891330
Pubmed	The role of phosphorylation and degradation of hPER protein oscillation in normal human fibroblasts.	PER3 PER2	2.50e-05	3	101	2	14712925
Pubmed	Usp9X Controls Ankyrin-Repeat Domain Protein Homeostasis during Dendritic Spine Development.	ANK3 USP9X	2.50e-05	3	101	2	31813652
Pubmed	Molecular analysis of avian circadian clock genes.	PER3 PER2	2.50e-05	3	101	2	10891604
Pubmed	Period Family of Clock Genes as Novel Predictors of Survival in Human Cancer: A Systematic Review and Meta-Analysis.	PER3 PER2	2.50e-05	3	101	2	32849922
Pubmed	Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily.	MAG CD22	2.50e-05	3	101	2	7533044
Pubmed	Circadian clock regulates hepatic polyploidy by modulating Mkp1-Erk1/2 signaling pathway.	PER3 PER2	2.50e-05	3	101	2	29269828
Pubmed	PER2 rs2304672, CLOCK rs1801260, and PER3 rs57875989 polymorphisms are not associated with juvenile myoclonic epilepsy.	PER3 PER2	2.50e-05	3	101	2	24892753
Pubmed	The complex relationship between the light-entrainable and methamphetamine-sensitive circadian oscillators: evidence from behavioral studies of Period-mutant mice.	PER3 PER2	2.50e-05	3	101	2	23869717
Pubmed	Zic2-dependent axon midline avoidance controls the formation of major ipsilateral tracts in the CNS.	EPHA6 LHX9 EPHA5	4.04e-05	23	101	3	24360543
Pubmed	An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome.	PER3 PER2	4.99e-05	4	101	2	11232563
Pubmed	Molecular analysis of mammalian timeless.	PER3 PER2	4.99e-05	4	101	2	9856466
Pubmed	Lack of Association between Genetic Polymorphism of Circadian Genes (PER2, PER3, CLOCK and OX2R) with Late Onset Depression and Alzheimer's Disease in a Sample of a Brazilian Population (Circadian Genes, Late-Onset Depression and Alzheimer's Disease).	PER3 PER2	4.99e-05	4	101	2	27335043
Pubmed	Endotoxin Disrupts Circadian Rhythms in Macrophages via Reactive Oxygen Species.	PER3 PER2	4.99e-05	4	101	2	27168152
Pubmed	The human synMuv-like protein LIN-9 is required for transcription of G2/M genes and for entry into mitosis.	RBL2 LIN9	4.99e-05	4	101	2	17159899
Pubmed	The collagen ColQ binds to LRP4 and regulates the activation of the Muscle-Specific Kinase-LRP4 receptor complex by agrin at the neuromuscular junction.	LRP4 AGRN	4.99e-05	4	101	2	37356721
Pubmed	Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome.	PER3 PER2	4.99e-05	4	101	2	15800623
Pubmed	Regulation of clock genes.	PER3 PER2	4.99e-05	4	101	2	10487202
Pubmed	Cloning and characterization of rat casein kinase 1epsilon.	PER3 PER2	4.99e-05	4	101	2	10899319
Pubmed	Blockade of Notch ligand δ1 promotes allograft survival by inhibiting alloreactive Th1 cells and cytotoxic T cell generation.	DLL1 STAT4	4.99e-05	4	101	2	21949024
Pubmed	Proteoglycans and their roles in brain cancer.	HS6ST2 CSPG4	4.99e-05	4	101	2	23281850
Pubmed	Tissue-intrinsic dysfunction of circadian clock confers transplant arteriosclerosis.	PER3 PER2	4.99e-05	4	101	2	21969583
Pubmed	The circadian clock protein Period 1 regulates expression of the renal epithelial sodium channel in mice.	PER3 PER2	4.99e-05	4	101	2	19587447
Pubmed	Expression of basic helix-loop-helix/PAS genes in the mouse suprachiasmatic nucleus.	PER3 PER2	4.99e-05	4	101	2	10077321
Pubmed	Visualizing and Quantifying Intracellular Behavior and Abundance of the Core Circadian Clock Protein PERIOD2.	PER3 PER2	4.99e-05	4	101	2	27374340
Pubmed	Relationship between APOE, PER2, PER3 and OX2R Genetic Variants and Neuropsychiatric Symptoms in Patients with Alzheimer's Disease.	PER3 PER2	4.99e-05	4	101	2	36901420
Pubmed	Organization of the murine Cd22 locus. Mapping to chromosome 7 and characterization of two alleles.	MAG CD22	4.99e-05	4	101	2	8100843
Pubmed	Comparison of β-adrenergic and glucocorticoid signaling on clock gene and osteoblast-related gene expressions in human osteoblast.	PER3 PER2	4.99e-05	4	101	2	22217103
Pubmed	The ins and outs of circadian timekeeping.	PER3 PER2	4.99e-05	4	101	2	10508692
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ASXL1 THSD7A CDK12 AATK HELZ2 WDFY3	5.21e-05	225	101	6	12168954
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	AOC1 WWOX ANK3 ASH1L ZNF318 PRAMEF2 IGF2R POP1 BOP1 FUBP3 AGRN MINDY1	7.37e-05	1084	101	12	11544199
Pubmed	Mammalian circadian autoregulatory loop: a timeless ortholog and mPer1 interact and negatively regulate CLOCK-BMAL1-induced transcription.	PER3 PER2	8.30e-05	5	101	2	9856465
Pubmed	Disturbance of circadian gene expression in hepatocellular carcinoma.	PER3 PER2	8.30e-05	5	101	2	18444243
Pubmed	Intercellular coupling confers robustness against mutations in the SCN circadian clock network.	PER3 PER2	8.30e-05	5	101	2	17482552
Pubmed	Agrin-Lrp4-Ror2 signaling regulates adult hippocampal neurogenesis in mice.	LRP4 AGRN	8.30e-05	5	101	2	31268420
Pubmed	TRAF6 mediates ubiquitination of KIF23/MKLP1 and is required for midbody ring degradation by selective autophagy.	WDFY3 NBR1	8.30e-05	5	101	2	24128730
Pubmed	Control of intracellular dynamics of mammalian period proteins by casein kinase I epsilon (CKIepsilon) and CKIdelta in cultured cells.	PER3 PER2	8.30e-05	5	101	2	11865049
Pubmed	Microglia activation in Niemann-Pick disease, type C1 is amendable to therapeutic intervention.	MCOLN1 CD22	8.30e-05	5	101	2	29617956
Pubmed	Expression of insulin-like growth factor (IGF), IGF receptor, and IGF-binding protein messenger ribonucleic acids in luteinized granulosa cells from different size follicles after controlled ovarian hyperstimulation.	IGF2R IGFBP5	8.30e-05	5	101	2	12005306
Pubmed	Altered patterns of sleep and behavioral adaptability in NPAS2-deficient mice.	PER3 PER2	8.30e-05	5	101	2	12843397
Pubmed	The IGFs and their binding proteins in murine development.	IGF2R IGFBP5	8.30e-05	5	101	2	7691099
Pubmed	Dimerization and nuclear entry of mPER proteins in mammalian cells.	PER3 PER2	8.30e-05	5	101	2	10837028
Pubmed	A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function.	PRDM11 IGFBP5 PDE8B	1.01e-04	31	101	3	23408906
Pubmed	Genetic variants associated with disordered eating.	WWOX PDE8A ATP8A2 SPHKAP	1.03e-04	83	101	4	23568457
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MAP1B USP9X ZNF318 IGF2R POP1 HELZ2 BOP1 FUBP3 SON	1.24e-04	653	101	9	22586326
Pubmed	A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock.	PER3 PER2	1.24e-04	6	101	2	9989497
Pubmed	Molecular bases for circadian clocks.	PER3 PER2	1.24e-04	6	101	2	9988221
Pubmed	Macromolecular Assemblies of the Mammalian Circadian Clock.	PER3 PER2	1.24e-04	6	101	2	28886335
Pubmed	Rhythmic diurnal gene expression in human adipose tissue from individuals who are lean, overweight, and type 2 diabetic.	PER3 PER2	1.24e-04	6	101	2	21411511
Pubmed	Zinc partitions insulin-like growth factors (IGFs) from soluble IGF binding protein (IGFBP)-5 to the cell surface receptors of BC3H-1 muscle cells.	IGF2R IGFBP5	1.24e-04	6	101	2	14566968
Pubmed	The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb.	RBL2 LIN9	1.24e-04	6	101	2	30206359
Pubmed	The role of polymorphisms in circadian pathway genes in breast tumorigenesis.	PER3 PER2	1.24e-04	6	101	2	20978934
Pubmed	Phosphorylation of clock protein PER1 regulates its circadian degradation in normal human fibroblasts.	PER3 PER2	1.24e-04	6	101	2	14750904
Pubmed	Genome-wide association analysis identifies six new loci associated with forced vital capacity.	WWOX PRDM11	1.24e-04	6	101	2	24929828
Cytoband	6q27	FAM120B DLL1 FRMD1	2.49e-04	55	101	3	6q27
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	CSPG4 AGRN	2.89e-04	7	68	2	570
GeneFamily	Fibronectin type III domain containing\|Sterile alpha motif domain containing\|EPH receptors	EPHA6 EPHA5	1.23e-03	14	68	2	1095
GeneFamily	Zinc fingers C2H2-type\|PR/SET domain family	PRDM11 PRDM6	1.83e-03	17	68	2	1197
GeneFamily	DNA polymerases	REV3L POLN	3.35e-03	23	68	2	535
GeneFamily	Phosphodiesterases	PDE8A PDE8B	3.65e-03	24	68	2	681
Coexpression	FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2	STARD13 PDE8A CPE KANK2 PXDN PDE8B CSPG4 CCDC102B AGRN EPB41L1	2.54e-07	303	100	10	M39040
Coexpression	ULE_SPLICING_VIA_NOVA2	RAP1GAP ANK3 KCNMA1 AGRN EPHA5	6.27e-07	43	100	5	MM666
Coexpression	ULE_SPLICING_VIA_NOVA2	RAP1GAP ANK3 KCNMA1 AGRN EPHA5	6.27e-07	43	100	5	M1551
Coexpression	BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP	THSD7A PDE8A REV3L IGFBP5	5.80e-06	31	100	4	M816
Coexpression	AIZARANI_LIVER_C33_STELLATE_CELLS_2	ANK3 MAP1B CPE KANK2 PXDN IGFBP5	9.02e-06	126	100	6	M39132
Coexpression	NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN	ASXL1 FAM234A PDE8A ANK3 RBL2 MKNK2 CPE POM121 IGFBP5 AGRN NBR1	3.74e-05	648	100	11	M14371
Coexpression	BUSSLINGER_GASTRIC_G_CELLS	ANK3 MAP1B CPE PDE8B LRP4	3.75e-05	98	100	5	M40018
Coexpression	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6	USP9X MKNK2 PER3 PER2	5.45e-05	54	100	4	MM537
Coexpression	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6	USP9X MKNK2 PER3 PER2	5.86e-05	55	100	4	M1284
Coexpression	BUSSLINGER_GASTRIC_X_CELLS	MAP1B CPE REV3L IGFBP5 PDE8B KCNMA1	9.35e-05	191	100	6	M40019
Coexpression	WONG_ADULT_TISSUE_STEM_MODULE	PDE8A ANK3 ASH1L SLCO3A1 STAT4 IGF2R PXDN IGFBP5 KCNMA1 LRP4 EPHA5	9.72e-05	721	100	11	M1999
Coexpression	GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN	PDE8A USP9X ASH1L ZNF318 ADIPOR2 SON	1.17e-04	199	100	6	M5799
Coexpression	GSE11924_TFH_VS_TH1_CD4_TCELL_UP	WWOX TCIRG1 CPE MCOLN1 AGRN NBR1	1.17e-04	199	100	6	M3151
Coexpression	GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP	PDE8A USP9X SLCO3A1 AATK PER2 CD22	1.20e-04	200	100	6	M8843
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_100	MAP1B USP9X REV3L AGRN	1.34e-05	33	94	4	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500	ANK3 MAP1B CDK12 USP9X REV3L KANK2 AGRN	4.01e-05	209	94	7	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	ANK3 MAP1B CDK12 USP9X REV3L KANK2 IGFBP5 AGRN SON	5.28e-05	385	94	9	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAP1B CPE KANK2 IGFBP5 CSPG4 KCNMA1 CCDC102B PRDM6	1.12e-08	189	100	8	975e7aa3b862a8b07c2ab8426a14f5cc54998aca
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAP1B CPE KANK2 IGFBP5 KCNMA1 LRP4 CCDC102B PRDM6	1.26e-08	192	100	8	992d08092edbc68c47b945deb8708379738c239a
ToppCell	metastatic_Brain-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	MAP1B SLCO3A1 CPE PDE8B CSPG4 CCDC102B AGRN EPB41L1	1.61e-08	198	100	8	86a4c8e859ce11a95875f8844963baeb1ba898ec
ToppCell	LPS_IL1RA-Mesenchymal_myocytic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MAP1B CPE KANK2 IGFBP5 PDE8B CSPG4 KCNMA1 CCDC102B	1.74e-08	200	100	8	77631c471cc5d453a749784f838cfa6408caf09b
ToppCell	COVID-19-Heart-Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	PDE8A MAP1B CPE STAT4 CSPG4 CCDC102B EPB41L1	1.98e-07	184	100	7	21790cdfa3b4036ad413fd44b94e31563116f25f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAP1B CPE KANK2 IGFBP5 KCNMA1 CCDC102B PRDM6	2.13e-07	186	100	7	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAP1B CPE IGFBP5 CSPG4 KCNMA1 CCDC102B PRDM6	2.13e-07	186	100	7	a95744b8649096bd7cfc3591a02841fa411085b3
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	STARD13 MAP1B NCKAP5 CPE CSPG4 CCDC102B EPB41L1	2.38e-07	189	100	7	1ff4f8da572bdc6356e9df9f41a7f62c81d4c570
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAP1B CPE KANK2 IGFBP5 KCNMA1 CCDC102B PRDM6	2.38e-07	189	100	7	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAP1B CPE KANK2 IGFBP5 KCNMA1 LRP4 PRDM6	2.38e-07	189	100	7	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAP1B KANK2 IGFBP5 KCNMA1 LRP4 CCDC102B PRDM6	2.55e-07	191	100	7	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B USP9X ASH1L CPE REV3L SPHKAP SON	2.94e-07	195	100	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B USP9X ASH1L CPE REV3L SPHKAP SON	2.94e-07	195	100	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer\|World / Primary Cells by Cluster	THSD7A ANK3 CPE LHX9 SPHKAP KCNMA1 EPHA5	3.15e-07	197	100	7	41e823b14697827f657b13adb3afa581bd91a9cb
ToppCell	Tracheal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	STARD13 MAP1B NCKAP5 CPE FGF23 CSPG4 CCDC102B	3.37e-07	199	100	7	aaa460c389cd6d38a13ba1a446f91a94f9573ad8
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	THSD7A PDE8A MAP1B IGFBP5 CCDC102B EPB41L1	3.40e-06	181	100	6	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	LA-07._Pericyte\|World / Chamber and Cluster_Paper	PDE8A MAP1B CPE IGFBP5 CCDC102B EPB41L1	3.62e-06	183	100	6	e3835db4795362b0442d5893baf2a78efcc20428
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B SLCO3A1 CPE KANK2 CSPG4 CCDC102B	3.85e-06	185	100	6	51dfe6ac7df8b330343b37e3bee71e5c65267189
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B SLCO3A1 CPE KANK2 CSPG4 CCDC102B	3.85e-06	185	100	6	a8c02cec3c414f3a0da9f2d6d28ce563b0030705
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 MAP1B KANK2 IGFBP5 KCNMA1 PRDM6	3.98e-06	186	100	6	6add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAG CAPS DLL1 IGFBP5 P2RX2 MINDY1	3.98e-06	186	100	6	c2b65b8345487710704c3eb043e9bef2e2b1ff27
ToppCell	RV-07._Pericyte\|RV / Chamber and Cluster_Paper	MAP1B CPE STAT4 IGFBP5 CCDC102B EPB41L1	3.98e-06	186	100	6	c533b264fbe12bc35467486fc7fbde24ba968fe1
ToppCell	RV-07._Pericyte\|World / Chamber and Cluster_Paper	PDE8A MAP1B CPE IGFBP5 CCDC102B EPB41L1	4.10e-06	187	100	6	dc274d6bbda619a2c914d84e2b4069cfef1739d1
ToppCell	COPD-Stromal-Pericyte\|Stromal / Disease state, Lineage and Cell class	MAP1B NCKAP5 STAT4 PDE8B CSPG4 CCDC102B	4.10e-06	187	100	6	406ecd1dabb3ed8d871aef159f7bd1e383434953
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B KANK2 CSPG4 KCNMA1 CCDC102B PRDM6	4.23e-06	188	100	6	b2d68a32314e9b099ed74d974079ad96359d1ae3
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B KANK2 IGFBP5 CSPG4 KCNMA1 PRDM6	4.23e-06	188	100	6	879de94924de978478696fc7838e05a4d795b905
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B KANK2 IGFBP5 CSPG4 KCNMA1 PRDM6	4.36e-06	189	100	6	7fbe855bfdb47d35e040b04a80fe4b729a3764e8
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-myocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B KANK2 IGFBP5 CSPG4 KCNMA1 PRDM6	4.36e-06	189	100	6	ab7ece0a517499b70b7754720d3e434765363af6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B KANK2 IGFBP5 CSPG4 KCNMA1 PRDM6	4.36e-06	189	100	6	06b35abecd29f902cf251fcc1f6ad33db7ab08a2
ToppCell	Fibroblasts-CD55+_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	PLXNA3 ANK3 CAPS IGFBP5 HAS1 EPB41L1	4.49e-06	190	100	6	b4088128f5acf53f43244c9af9fe44e033f1a57a
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CPE KANK2 IGFBP5 CSPG4 KCNMA1 PRDM6	4.49e-06	190	100	6	73d94fbae92029745989a8712eed8b99fd84c193
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CPE KANK2 IGFBP5 KCNMA1 CCDC102B PRDM6	4.63e-06	191	100	6	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 CPE KANK2 IGFBP5 KCNMA1 PRDM6	4.63e-06	191	100	6	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	Fibroblasts-CD55+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	ANK3 CAPS IGFBP5 CSPG4 HAS1 EPB41L1	4.92e-06	193	100	6	8f4bf9a2fbedae35432dad96730b00c70185874c
ToppCell	10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ANK3 IGFBP5 CSPG4 KCNMA1 HAS1 EPB41L1	5.06e-06	194	100	6	69362e13158033de44f90f3773db6c0f27de8cb3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B CPE KANK2 CSPG4 KCNMA1 PRDM6	5.06e-06	194	100	6	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B CPE KANK2 IGFBP5 CSPG4 CCDC102B	5.22e-06	195	100	6	9ab3c5b0fb12d406408122a535b717bfe184bbcf
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B CPE KANK2 IGFBP5 CSPG4 CCDC102B	5.22e-06	195	100	6	21263d138c81f6a0219f2cd93126cfafd35732b2
ToppCell	Parenchymal-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MAP1B NCKAP5 CPE IGFBP5 CSPG4 CCDC102B	5.69e-06	198	100	6	0dc5806714fb3d3983e9d19fa7a108e93a8090ed
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAG ANK3 SLCO3A1 AMER2 AATK ADIPOR2	5.86e-06	199	100	6	214a6a267e77e5508867b9eb48c4fbc7855ed0a0
ToppCell	Tracheal-10x5prime-Stromal-Pericyte\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MAP1B NCKAP5 CPE FGF23 CSPG4 CCDC102B	5.86e-06	199	100	6	cefc3b50f65e95da850e4720c7b44bf584073491
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MAP1B KANK2 IGFBP5 CSPG4 KCNMA1 CCDC102B	6.03e-06	200	100	6	f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MAP1B CPE KANK2 IGFBP5 CSPG4 CCDC102B	6.03e-06	200	100	6	a3a1e35934d676c39f917652e50c502cb2f613c1
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MAP1B CPE KANK2 PDE8B CSPG4 CCDC102B	6.03e-06	200	100	6	4e1e19214aeebbdca004de7faaf4cc9d18498591
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MAP1B CPE KANK2 PDE8B CSPG4 CCDC102B	6.03e-06	200	100	6	b22cae282591d8dead9869c2adbb9632615f50f7
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MAP1B CPE KANK2 IGFBP5 CSPG4 CCDC102B	6.03e-06	200	100	6	c06426f877919bdd267ea2fd7e7973c6619832ae
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MAP1B CPE KANK2 IGFBP5 CSPG4 CCDC102B	6.03e-06	200	100	6	67dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte\|LPS_only / Treatment groups by lineage, cell group, cell type	MAP1B KANK2 IGFBP5 PDE8B CSPG4 CCDC102B	6.03e-06	200	100	6	8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	MAP1B KANK2 IGFBP5 SPHKAP KCNMA1 LRP4	6.03e-06	200	100	6	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	THSD7A ANK3 MAP1B CPE AMER2 EPHA5	6.03e-06	200	100	6	04699d1149a143b96d6f292c0d70c4d3e6dfc611
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_only / Treatment groups by lineage, cell group, cell type	MAP1B KANK2 AMER2 IGFBP5 CSPG4 CCDC102B	6.03e-06	200	100	6	7c62678cf408aaaf98d6df0fb27814d2007c4521
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLEKHG4B PXDN P2RX2 CSPG4 SHCBP1L	1.79e-05	143	100	5	27e06327f96cb72bd111ea6ece6307e5ebb3a146
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLEKHG4B PXDN P2RX2 CSPG4 SHCBP1L	1.79e-05	143	100	5	4edef95ae2a1ef4fc4b0d4fadf75bfc54b583932
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HS6ST2 DLL1 FZD9 LRP4 POLN	3.06e-05	160	100	5	6215ac6123a295f3c2f033786602a57b2e2e1177
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLCO3A1 PXDN PDE8B CSPG4 KATNIP	4.70e-05	175	100	5	12f5fd83c7710fc0c77406f765d9cbd133433b8b
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MAG ANK3 CPE AATK CCDC191	4.70e-05	175	100	5	bb898796662b97f7459b7dda7cecf6a9bde8b055
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ATP8A2 CPE FZD9 CSPG4 KCNMA1	4.82e-05	176	100	5	77c3da2eaa072a6baefb5087fd07ec18c5e271cd
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAG ASXL1 DLL1 IGFBP5 MINDY1	4.82e-05	176	100	5	6c7edf1cb38644500bce6c5a1dd90bbe17415cdb
ToppCell	droplet-Fat-SCAT-30m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAG PKDREJ AATK IGFBP5 LRP4	5.09e-05	178	100	5	5cf12927f0756c4d8a289fe4308d736382e6212e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ASXL1 DLL1 IGFBP5 CD22 MINDY1	5.09e-05	178	100	5	51d2188406f04329311b2efd1108fc36617a860e
ToppCell	droplet-Bladder-BLADDER-1m-Endothelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAG SP100 AATK CSPG4 POP1	5.09e-05	178	100	5	6bef4ef48f649c6e38ae732bc08e6d7814db588b
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MAG DLL1 IGFBP5 P2RX2 MINDY1	5.09e-05	178	100	5	3d6d03bc57062f74ba19fc675dd36b12b6c7115d
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KANK2 IGFBP5 SPHKAP LRP4 PRDM6	5.23e-05	179	100	5	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ATP8A2 DLL1 PXDN IGFBP5 PRDM6	5.23e-05	179	100	5	a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d
ToppCell	AT1_cells-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	CRYBG2 NCKAP5 KANK2 AATK PXDN	5.37e-05	180	100	5	ff4728782c3ec814ba071cc22b7894abdd9da837
ToppCell	COVID-19-Heart-Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE8A MAP1B CPE CSPG4 CCDC102B	5.51e-05	181	100	5	33cac65ed1ea5e7bd72250495df4f850b143d5aa
ToppCell	RA-07._Pericyte\|World / Chamber and Cluster_Paper	THSD7A PDE8A MAP1B CPE CCDC102B	5.66e-05	182	100	5	2075efeae633550fb2eb026d0dfd741c8252482e
ToppCell	wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	EPHA6 CPE FZD9 CSPG4 FUBP3	5.66e-05	182	100	5	00a148b1e499bf16325491536d187d4dd6b70c06
ToppCell	tumor_Lung-Fibroblasts-Pericytes\|tumor_Lung / Location, Cell class and cell subclass	MAP1B CPE PDE8B CSPG4 CCDC102B	5.80e-05	183	100	5	a03dd563af9b15cb1f5de5732a229405a9f82d84
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	SP100 CDK12 USP9X ASH1L HELZ2	5.80e-05	183	100	5	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP1B CPE IGFBP5 CSPG4 PRDM6	5.80e-05	183	100	5	b4f29dd3994009bb5eb769d36d95886664e7f87d
ToppCell	LV-07._Pericyte\|World / Chamber and Cluster_Paper	MAP1B CPE IGFBP5 CCDC102B EPB41L1	5.80e-05	183	100	5	273db6a3b00a93ca852498471187b642b5368185
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B KANK2 IGFBP5 CSPG4 KCNMA1	5.80e-05	183	100	5	61a73de857f4ae02dcba3af348f436f602b28ff2
ToppCell	facs-Heart-RV-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AATK IGFBP5 PDE8B CSPG4 EPB41L1	5.96e-05	184	100	5	9c20b50f8d6ac689d41d5440c835f9db8d04758b
ToppCell	Mesenchymal_cells-Chondrocytes\|World / Lineage and Cell class	RAP1GAP CPE FZD9 CSPG4 KCNMA1	5.96e-05	184	100	5	1e03f9f08de5ad4d45388a95afad9f23ff0d0e28
ToppCell	facs-Heart-RV-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AATK IGFBP5 PDE8B CSPG4 EPB41L1	5.96e-05	184	100	5	31dbe6119a3bcd266ae5e9b340c853d9ff680dce
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 IGFBP5 SPHKAP LRP4 PRDM6	6.11e-05	185	100	5	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	Control-Myeloid-Macrophage_Alveolar\|World / Disease state, Lineage and Cell class	CPE MCOLN1 KCNMA1 ADIPOR2 EPB41L1	6.11e-05	185	100	5	85cb81759589a26d83676cffbf2bc37399683c10
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 THSD7A ANK3 PLEKHG4B NPAP1	6.11e-05	185	100	5	d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08
ToppCell	COVID-19-Fibroblasts-Pericytes\|COVID-19 / group, cell type (main and fine annotations)	MAP1B NCKAP5 PDE8B CSPG4 CCDC102B	6.11e-05	185	100	5	4905adaeeffd353e089578e5ea614437dbe794e6
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 IGFBP5 SPHKAP LRP4 PRDM6	6.11e-05	185	100	5	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	THSD7A NCKAP5 PXDN IGFBP5 LRP4	6.11e-05	185	100	5	0b5a0df58ae2ad8261f40f152775747af4f3937a
ToppCell	LV-07._Pericyte\|LV / Chamber and Cluster_Paper	MAP1B CPE STAT4 IGFBP5 CCDC102B	6.11e-05	185	100	5	acb38eba871ec72f2a8136a33b87d33b8c85465d
ToppCell	droplet-Lung-LUNG-30m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO3A1 NCKAP5 CPE DLL1 IGFBP5	6.27e-05	186	100	5	41f1674afc17661eccaa779cdeb663db5e45685d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1B KANK2 PDE8B CSPG4 CCDC102B	6.27e-05	186	100	5	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	droplet-Lung-LUNG-30m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO3A1 NCKAP5 CPE DLL1 IGFBP5	6.27e-05	186	100	5	aa006650cf21a2c51dfe1091681f67fdad939107
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAG RAP1GAP ANK3 AATK EPHA5	6.43e-05	187	100	5	16e55d802fc4e71878305e61ad03806aabd59537
ToppCell	facs-Heart-LA-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO3A1 CPE PDE8B CSPG4 EPB41L1	6.43e-05	187	100	5	a12f383b02b07af32cc53a154685df8dba8fbd3f
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MAP1B CPE CSPG4 KCNMA1 PRDM6	6.43e-05	187	100	5	218c9b4f28499389c43005d9626af2ac01066027
ToppCell	facs-Heart-LA-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLCO3A1 CPE PDE8B CSPG4 EPB41L1	6.43e-05	187	100	5	c40c152fa14e6afc9188549534b64ccbaded56b3
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B CPE STAT4 CSPG4 CCDC102B	6.43e-05	187	100	5	ec4b694487cc446999c7b27b119950a4f252c4b3
ToppCell	droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8A2 SLCO3A1 CPE FZD9 IGFBP5	6.43e-05	187	100	5	9c9ae8725905ba0cfe407878006ed06c2480fb72
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B CPE STAT4 CSPG4 CCDC102B	6.43e-05	187	100	5	530e4e6d91b5c0d9aa4543caa2b734a1674c5788
ToppCell	droplet-Lung-LUNG-1m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP8A2 SLCO3A1 CPE FZD9 IGFBP5	6.43e-05	187	100	5	9e9460e57cdc9cd0a0de2866b140e06d0bc19a8f
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MAP1B CPE CSPG4 KCNMA1 PRDM6	6.43e-05	187	100	5	c7ac4b328efc2ebb72f71154661914193ff402ca
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ANK3 NCKAP5 STAT4 PDE8B EPHA5	6.59e-05	188	100	5	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 KANK2 IGFBP5 KCNMA1 PRDM6	6.59e-05	188	100	5	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ATP8A2 SLCO3A1 CPE FZD9 IGFBP5	6.59e-05	188	100	5	dc52dd2957be3f40001f0a56f3d9ac9d66ea466e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 KANK2 IGFBP5 KCNMA1 PRDM6	6.59e-05	188	100	5	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	15-Distal-Mesenchymal-Pericyte\|Distal / Age, Tissue, Lineage and Cell class	SLCO3A1 CPE AMER2 CSPG4 CCDC102B	6.59e-05	188	100	5	4963382e54aac06bf5047c7d725393db70667ee7
Drug	C12H10O2	WWOX TCIRG1 HAS1	2.21e-05	13	99	3	CID000016615
Drug	Alsterpaullone; Up 200; 10uM; MCF7; HT_HG-U133A	SP100 ASH1L NCAPH2 ZMAT3 PDE8B KCNMA1 AGRN	2.25e-05	194	99	7	7051_UP
Drug	Oxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A	SP100 NCAPH2 ZNF318 IGFBP5 KCNMA1 NPRL3 AGRN	2.40e-05	196	99	7	6309_DN
Drug	Flavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; PC3; HT_HG-U133A	NCAPH2 ZNF318 IGFBP5 KATNIP IL17RA WDFY3 EPB41L1	2.48e-05	197	99	7	6326_DN
Drug	Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; PC3; HT_HG-U133A	STAT4 AATK PER2 CD22 EIF4EBP2 AGRN EPHA5	2.48e-05	197	99	7	3686_UP
Drug	resveratrol; Down 200; 50uM; PC3; HG-U133A	CDK12 PRDM11 PDE8B POP1 BUB1B IL17RA EPB41L1	2.48e-05	197	99	7	662_DN
Drug	Delcorine; Up 200; 8.4uM; HL60; HT_HG-U133A	STARD13 PLXNA3 THSD7A NCAPH2 CD22 PDE8B EIF4EBP2	2.56e-05	198	99	7	2178_UP
Drug	Salbutamol [18559-94-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A	MAG WWOX MCOLN1 FRMD1 IGFBP5 PDE8B EIF4EBP2	2.56e-05	198	99	7	4700_UP
Disease	carpal tunnel syndrome	AOC1 MKNK2 KANK2 MTMR11 RUSC1-AS1	1.04e-05	89	95	5	EFO_0004143
Disease	Advanced Sleep-Phase Syndrome, Familial	PER3 PER2	3.07e-05	3	95	2	C1858496
Disease	advanced sleep phase syndrome (is_implicated_in)	PER3 PER2	6.13e-05	4	95	2	DOID:0050628 (is_implicated_in)
Disease	Myeloid Leukemia, Chronic	ASXL1 PER3 PER2	1.11e-04	29	95	3	C0023473
Disease	Malignant neoplasm of breast	RAP1GAP WWOX WDR88 ZNF318 DLL1 PKDREJ MCOLN1 STAT4 PER3 IGFBP5 PER2 POP1	1.72e-04	1074	95	12	C0006142
Disease	acisoga measurement	AOC1 IGF2R	2.13e-04	7	95	2	EFO_0800068
Disease	heel bone mineral density, urate measurement	EPHA6 ATP13A5 LIN9 PDE8B SON	3.13e-04	182	95	5	EFO_0004531, EFO_0009270
Disease	severe acute respiratory syndrome, COVID-19	WWOX THSD7A USP9X ATP8A2 PXDN KCNMA1 PRDM6	6.14e-04	447	95	7	EFO_0000694, MONDO_0100096
Disease	hair morphology measurement	WWOX THSD7A CCDC102B	7.12e-04	54	95	3	EFO_0007821
Disease	language measurement	MAG ANK3 ATP8A2 ATP13A5	9.40e-04	134	95	4	EFO_0007797
Disease	Abnormality of chromosome segregation	THSD7A FZD9 AGRN	9.69e-04	60	95	3	HP_0002916
Disease	idiopathic dilated cardiomyopathy	FAM120B WWOX THSD7A	9.69e-04	60	95	3	EFO_0009094
Disease	Myasthenic Syndromes, Congenital, Slow Channel	LRP4 AGRN	1.20e-03	16	95	2	C0751885
Disease	phosphorus measurement	RAP1GAP FGF23	1.20e-03	16	95	2	EFO_0004861
Disease	Congenital Myasthenic Syndromes, Postsynaptic	LRP4 AGRN	1.35e-03	17	95	2	C0751883
Disease	Congenital Myasthenic Syndromes, Presynaptic	LRP4 AGRN	1.69e-03	19	95	2	C0751884
Disease	peripheral neuropathy, response to docetaxel trihydrate	ATP8A2 SPHKAP	1.69e-03	19	95	2	EFO_0003100, GO_1902519
Disease	smoking status measurement, diastolic blood pressure	ZNF318 PRDM11 NPRL3 FER1L5	1.77e-03	159	95	4	EFO_0006336, EFO_0006527
Disease	cancer (implicated_via_orthology)	WWOX RBL2 DLL1 KANK2 FRMD1	1.77e-03	268	95	5	DOID:162 (implicated_via_orthology)
Disease	Lewy Body Disease	MAG IGF2R	2.27e-03	22	95	2	C0752347
Disease	complement factor H-like 1 protein measurement	THSD7A ATP8A2	2.27e-03	22	95	2	EFO_0600092
Disease	S-7-hydroxywarfarin to S-warfarin ratio measurement	STARD13 WWOX POU4F3	2.30e-03	81	95	3	EFO_0803334
Disease	testosterone measurement	STARD13 AOC1 WWOX PDE8A ANK3 HS6ST2 ZNF318 PKDREJ FZD9 PER3 PDE8B	2.65e-03	1275	95	11	EFO_0004908
Disease	Myasthenic Syndromes, Congenital	LRP4 AGRN	2.70e-03	24	95	2	C0751882
Disease	erythrocyte count, mean corpuscular hemoglobin concentration, mean corpuscular volume, hematocrit, obsolete_red blood cell distribution width, mean corpuscular hemoglobin	FAM234A NPRL3	2.93e-03	25	95	2	EFO_0004305, EFO_0004348, EFO_0004526, EFO_0004527, EFO_0004528, EFO_0005192
Disease	Hashimoto's thyroiditis	STAT4 PDE8B	3.17e-03	26	95	2	EFO_0003779
Disease	response to angiotensin-converting enzyme inhibitor, response to angiotensin receptor blocker, angioedema	THSD7A KCNMA1	3.17e-03	26	95	2	EFO_0005325, EFO_0005532, EFO_0010735

Protein segments in the cluster

Peptide	Gene	Start	Entry
ETARQPVMTPCKIEP	BUB1B	346	O60566
TPCPRTEMASARIGD	BOP1	106	Q14137
PCPDRPASQRMWRID	FAM234A	71	Q9H0X4
VDPPSDPSADRICLM	AMER2	351	Q8N7J2
EQCDPRPVDREVPMI	ASH1L	2626	Q9NR48
APEMVARFCRSETVP	ATP13A5	626	Q4VNC0
PRRTPTMPQEEAAAC	CDK12	1241	Q9NYV4
MERPRSPQCSAPASA	C6orf226	1	Q5I0X4
TQASCPEPRPSMDAV	CAPS	76	Q13938
EVSVTARVPMPSCLR	CSPG4	521	Q6UVK1
PIVRACESMERSCPG	LINC00303	96	Q3SY05
TMACTRPPSAPRNAI	EPHA5	351	P54756
EMLLRPESCPARQAP	AGRN	341	O00468
DRRNSPMAQTPPCHL	EIF4EBP2	61	Q13542
VQRWIPEDRDCSMPP	AOC1	726	P19801
PVDICTAKPRDIPMN	SERPINC1	36	P01008
SCPPMRESDTRQENL	ASXL1	871	Q8IXJ9
LAREPSSDDFCRMPP	ATP8A2	456	Q9NTI2
DPQIPECAALVRRTM	POLN	811	Q7Z5Q5
MNEPTENRLGCSRTP	ADIPOR2	1	Q86V24
PMVVTDCIQVDPPER	MCOLN1	186	Q9GZU1
DNENRVPTCEEVMPP	RBL2	611	Q08999
VPTCEEVMPPQNLER	RBL2	616	Q08999
RGACSTPDMPQFEPV	EPB41L1	681	Q9H4G0
RHSATVSCPEMPDTP	IL17RA	296	Q96F46
GLQPADQPTDMRRRC	LIN9	421	Q5TKA1
EECPRPMSISPPDFS	MAP1B	1611	P46821
EVSCMVPDNCPELRP	MAG	156	P20916
IPVTMEVPCDSRGQR	KCNMA1	71	Q12791
ENRMPEPRSRQPSSC	MTMR11	26	A4FU01
EPPAEECRMTPRHAG	HHLA3	16	Q9XRX5
APAVFPDQERMCSRP	KATNIP	301	O60303
ACPATRATPPSAMGR	PER2	961	O15055
RPSESPDQMRRNTCP	PER3	936	P56645
VEDNARCYPPPSMRV	PLXNA3	71	P51805
CRAEDNSCPFRPPAM	LHX9	6	Q9NQ69
QCSARPDMPASQPID	MKNK2	41	Q9HBH9
CAPENTLPTPMVLQR	MKNK2	371	Q9HBH9
PVVMPVFDRNTCSIP	PDE8A	761	O60658
PVVMPVFDRNTCSIP	PDE8B	816	O95263
CLMASPSEEEPRPRE	NPRL3	411	Q12980
SPERAAQVMGPPDRC	FUBP3	296	Q96I24
EMTECPAALAPVRPT	KDM4A	426	O75164
IRACSMPQELPQSPR	MINDY1	91	Q8N5J2
SPRMVPRAVYLPNCD	IGFBP5	206	P24593
RTVVCNDPDMTLPPA	LRIT1	41	Q9P2V4
QRMPNECKPITESPE	PRDM6	576	Q9NQX0
SDLRRSEVPCAPMPK	POP1	736	Q99575
MVCSPVTVRIAPPDR	POM121	266	Q96HA1
LRPCPISAPSEQMVD	P2RX2	436	Q9UBL9
TPIPACRPMCEQARL	FZD9	106	O00144
RCMEPSPERPACSQQ	FRMD1	26	Q8N878
MDSLTERCRPQPLAA	LINC00315	1	P59091
HRPPADPCRGETETM	DLL1	576	O00548
RARMTPAPASCSQEL	FGF23	196	Q9GZV9
REEEPRTCQMLVNSP	CCDC191	611	Q8NCU4
QAPRTEPPCVGAMAR	CRYBG2	126	Q8N1P7
HPARPTQVSCSPLEM	CRYBG2	861	Q8N1P7
AMSDPNRPPCRKNDD	CPE	291	P16870
RCMEPDPEIPSAFNS	ADPRS	286	Q9NX46
TGPQSPCERTDIRMA	ANK3	4081	Q12955
MRQQDAPKPTPAACR	HAS1	1	Q92839
PPVFRSQEVVETMCP	KANK2	376	Q63ZY3
MALPACAVREFEPPR	HS6ST2	1	Q96MM7
REPVPMLPASLCQDV	HELZ2	1401	Q9BYK8
RGDMVAPASPPRDTC	CCDC102B	26	Q68D86
SEMQRPPPDCDDTVT	CD22	781	P20273
QEVPMCTGPESRREV	FAM120B	351	Q96EK7
ESRREVPMCSDPEPR	FAM120B	396	Q96EK7
MACTRPPSAPRNVVF	EPHA6	326	Q9UF33
SFVCRPEARPTNRPM	IGF2R	1611	P11717
PNPSSECMLRNVSVR	USP9X	1206	Q93008
PVCHRQSSMPDSRSP	SPHKAP	1231	Q2M3C7
EQVPGAREPRLMASC	STARD13	436	Q9Y3M8
PDPDLICRNRTATNM	SLCO3A1	161	Q9UIG8
LVMSQPDADRSCNPP	THSD7A	1506	Q9UPZ6
APLPRPCMSIDFRDI	FER1L5	16	A0AVI2
SCRVAESMAPDPRTL	AATK	216	Q6ZMQ8
THPMPSPEAVIQTRC	NCKAP5	1006	O14513
RVPHNTPVDVTPCMS	NBR1	576	Q14596
TECPTDGPARVMLQA	PKDREJ	181	Q9NTG1
GQPCSRRPDSSAMEV	PRDM11	71	Q9NQV5
PMYVRSPCDPDRDQR	PPP1R32	326	Q7Z5V6
QGSRMDEQRCSFPPP	RAP1GAP	6	P47736
EEAQPLPPVCVSRMR	SHCBP1L	101	Q9BZQ2
SCPAPRAQVHRSTPM	RUSC1-AS1	146	Q66K80
PEAMSKRQTAEDCPR	PRAMEF2	126	O60811
SCPQVPMEERISNLR	ODF3L1	101	Q8IXM7
SGSEAMRRVCLPAPQ	POU4F3	26	Q15319
VTRESPISMCVDSPP	NPAP1	511	Q9NZP6
EEQPMEVSVCRSPVP	NCAPH2	221	Q6IBW4
MLREREGAPEPASCV	NCAPH2	296	Q6IBW4
VVASAALRCPDPVPM	VPS51	756	Q9UID3
MASPPRCSPTAHDRE	WDR88	1	Q6ZMY6
RIMGRPRQEECSPQD	WDFY3	6	Q8IZQ1
SPEIMCQSSRQPRPA	SLC16A5	451	O15375
PRCWSPTDPRAEEIM	REV3L	1126	O60673
APQCVPLIMEPESRF	REV3L	2591	O60673
QPFMDVKPRDRTPDC	PLEKHG4B	1126	Q96PX9
FVVERQPCMPTHPQR	STAT4	316	Q14765
ATCSRPQIVPEPMDF	SP100	371	P23497
PCFSVMIPPNDSRAR	PXDN	856	Q92626
PTECMRDENESPIPC	PXDN	956	Q92626
RCMPSPEAQSEETAR	WWOX	381	Q9NZC7
LMDPRQACRTPSRDE	RHPN2P1	66	A8MT19
ILRDETRGPCPDMQS	ZNF790	66	Q6PG37
RIPRDLAMCVTPSGQ	ZMAT3	231	Q9HA38
VAVRCMLPSAPSAPI	ZNF318	736	Q5VUA4
VPERPVTCMVSETPA	SON	1276	P18583
SAVAHRIPCRDMPPT	TCIRG1	346	Q13488
EEPRCMDPAQRDAPL	ZNF500	236	O60304
HRRRPPVSTPCAMEN	LRP4	996	O75096